OCUL

Ocular Therapeutix Inc.

Price

$11.73

return (12m)

-3.38%

p/e

-7.31

p/bv

4.24

DIVIDEND YIELD

0.00%

OCUL price

Ocular Therapeutix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OCUL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

30.26%

3 months

42.70%

1 year

-3.38%

2 years

34.36%

5 years

17.18%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OCUL

Valuation

P/E

-7.31

Sector -4.38

Industry -4.38

P/BV

4.24

Sector 2.02

Industry 2.02

P/Revenue (PSR)

42.34

Sector -4.40

Industry -4.40

EV/EBITDA

-22.64

Sector -263.09

Industry -263.09

EV/EBIT

-22.09

Sector -702.90

Industry -702.90

P/EBITDA

-7.74

Sector -4.39

Industry -4.39

P/EBIT

-7.60

Sector -4.73

Industry -4.73

P/Total Assets

3.28

Sector 1.49

Industry 1.49

P/Net Current Assets

4.47

Sector -11.70

Industry -11.70

P/Working Capital

3.70

Sector -3.19

Industry -3.19

EPS

-1.34

Sector -2.14

Industry -2.14

BVPS

2.31

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

87.13%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-550.26%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-563.99%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

-57.96%

Sector -65.14%

Industry -65.14%

ROA

-44.90%

Sector -65.53%

Industry -65.53%

ROIC

-1,099.99%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

13.11

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.09

Sector -6.07

Industry -6.07

Net Debt / EBIT

6.92

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.01

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.14

Sector -0.05

Industry -0.05

Equity/Assets

0.77

Sector 0.41

Industry 0.41

Liabilities/Assets

0.23

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

3.64%

Sector -

Industry -

5Y Earnings CAGR

115.08%

Sector -

Industry -

Fundamentals OCUL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OCUL Ocular Therapeutix Inc.	$11.73	-4.71%	0.00%	-7.31	4.24	-57.96%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OCUL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ocular Therapeutix

Ocular Therapeutix Inc.

Average Investor10 user rating

4.0 (1 people)

United States

20 years

Founded: 2006

2014

Time since IPO - 12 years

181

Employees

Ocular Therapeutix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.20 billion, with shareholders equity totaling $520.04 million.

The company employs approximately 181 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ocular Therapeutix Inc. reported $52.05 million in revenue, generating net income of $-301.44 million.

Key financial metrics include a P/E ratio of -7.31, a price-to-book (P/B) ratio of 4.24, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OCUL.

Market cap

$2.20 billion

Net worth

$520.04 million

$520,040,000.00

Assets

$671.32 million

$671,320,000.00

Total Shares Outstanding

225.00 million

225,000,000

Average Daily Trading Volume

$2.54 million

$2,537,118.00

Sector

Health Care

Industry

Biotechnology

OCUL

OCUL revenue and profits

Financial Results OCUL

DRAG THE FRAME TO SEE MORE DATA

OCUL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Ocular Therapeutix (OCUL) today?

A cotação de Ocular Therapeutix (OCUL) hoje está em US$ 11.73, com uma variação de -3.38% em relação ao último ano. A cotação de Ocular Therapeutix (OCUL) iniciou o ano negociando na casa dos US$ 12.14 e hoje está em US$ 11.73. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ocular Therapeutix (OCUL) e dados de ações do Ibovespa e mercados internacionais.

Quando Ocular Therapeutix (OCUL) paga dividendos?

Ocular Therapeutix (OCUL) não distribuiu dividendos no último ano.

Is Ocular Therapeutix (OCUL) a good investment?

Atualmente, Ocular Therapeutix (OCUL) está cotada a US$ 11.73, com um P/L de -7.31, representando um desvio de -650% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -3.38 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -3.38%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ocular Therapeutix (OCUL) stock?

Investir em ações de Ocular Therapeutix (OCUL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ocular Therapeutix (OCUL) yield today?

A rentabilidade de Ocular Therapeutix (OCUL) foi de 30.26% no último mês, -3.38% no último ano e 17.18% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ocular Therapeutix (OCUL) hoje, o investimento total seria de US$ 1,173.00, com base na cotação atual de US$ 11.73.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,133.35
Em 5 anos: US$ 1,374.52
Em 10 anos: US$ 1,173.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OCUL

Ocular Therapeutix Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OCUL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OCUL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ocular Therapeutix

Ocular Therapeutix Inc.

United States

20 years

2014

181

PROFIT X PRICE OCUL

Financial Results OCUL

OCUL cash flow

Asset, Revenue and Profit Growth - OCUL

OCUL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions